v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Operating Activities    
Net income $ 163,301 $ 114,098
Depreciation and amortization 24,442 20,402
Gain on acquisition (35,492) 0
Net realized investment gains (35,151) (9,130)
Share-based compensation 4,708 5,072
Deferred income taxes 12,513 3,010
Policy acquisition costs, net amortization (net deferral) (4,245) 1,497
Other (6,056) (2,936)
Other changes in assets and liabilities, excluding effect of business combinations:    
Premiums receivable (10,563) 7,887
Reinsurance related assets and liabilities 1,812 (7,647)
Other assets (42,065) (1,133)
Reserve for losses and loss adjustment expenses (61,298) (54,730)
Unearned premiums 2,469 (12,864)
Other liabilities (26,647) (30,821)
Net cash provided (used) by operating activities (12,272) 32,705
Purchases of:    
Fixed maturities, available for sale (307,439) (347,146)
Equity securities, trading (53,339) (53,001)
Other investments (3,805) (158)
Funding of tax credit limited partnerships (32,332) (23,470)
(Investment in) distributions from unconsolidated subsidiaries, net (3,190) 582
Proceeds from sales or maturities of:    
Fixed maturities, available for sale 373,186 432,667
Equity securities, trading 59,400 22,921
Other investments 1,364 565
Net sales or maturities (purchases) of short-term investments (14,732) (48,654)
Cash received from acquisitions 22,780 0
Unsettled security transactions, net (3,102) 6,712
Cash received (paid) for other assets (3,571) (4,620)
Net cash provided (used) by investing activities 35,220 (13,602)
Financing Activities    
Dividends to shareholders (15,320) (15,270)
Other (6,945) (2,043)
Net cash provided (used) by financing activities (22,265) (17,313)
Increase (decrease) in cash and cash equivalents 683 1,790
Cash and cash equivalents at beginning of period 118,551 130,400
Cash and cash equivalents at end of period 119,234 132,190
Medmarc [Member]
   
Significant Non Cash Transactions Abstract    
Other Significant Noncash Transaction, Value of Consideration Given $ 153,700 $ 0